Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
13%
Ph phase_4
7
88%

Phase Distribution

1

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 4Post-market surveillance
7(87.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(2)
Other(5)

Detailed Status

unknown5
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (12.5%)
Phase 47 (87.5%)

Trials by Status

unknown563%
not_yet_recruiting113%
completed225%

Recent Activity

0 active trials
Showing 5 of 8
not_yet_recruitingearly_phase_1

The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication

NCT06777732
completedphase_4

Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

NCT05431075
completedphase_4

Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

NCT05049902
unknownphase_4

Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection

NCT05419674
unknownphase_4

Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

NCT04558502
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06777732Early Phase 1

The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication

Not Yet Recruiting
NCT05431075Phase 4

Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

Completed
NCT05049902Phase 4

Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

Completed
NCT05419674Phase 4

Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection

Unknown
NCT04558502Phase 4

Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

Unknown
NCT04907747Phase 4

Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication

Unknown
NCT04901117Phase 4

Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days

Unknown
NCT03571230Phase 4

Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8